These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 8009591)

  • 1. Clinical evaluation of induction immunosuppression with a murine IgG2b monoclonal antibody (BMA 031) directed toward the human alpha/beta-T cell receptor.
    Knight RJ; Kurrle R; McClain J; Racenberg J; Baghdahsarian V; Kerman R; Lewis R; van Buren CT; Kahan BD
    Transplantation; 1994 Jun; 57(11):1581-8. PubMed ID: 8009591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of allograft rejection by anti-T-cell receptor-alpha beta monoclonal antibodies preserving resistance to bacterial infection.
    Eto M; Yoshikai Y; Nishimura Y; Hiromatsu K; Maeda T; Nomoto K; Kong YY; Kubo RT; Kumazawa J; Nomoto K
    Immunology; 1994 Feb; 81(2):198-204. PubMed ID: 8157269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T10B9.1A-31 anti-T-cell monoclonal antibody: preclinical studies and clinical treatment of solid organ allograft rejection.
    Waid TH; Lucas BA; Amlot P; Janossy G; Yacoub M; Cammisuli S; Jezek D; Rhoades J; Brown S; Thompson JS
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):61-70. PubMed ID: 2479265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic immunosuppressive actions of cyclosporine with a mouse anti-rat alpha/beta-T cell receptor monoclonal antibody.
    Knight RJ; Kurrle R; Stepkowski S; Serino F; Chou TC; Kahan BD
    Transplantation; 1994 Jun; 57(11):1544-8. PubMed ID: 8009587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of anti-T-cell receptor alpha beta monoclonal antibody-induced side-effects by treatment with cyclosporin A without interference of monoclonal antibody-induced immunosuppression in mice.
    Murakami Y; Kong YY; Nishimura Y; Nomoto K; Umesue M; Omoto K; Maeda T; Nomoto K
    Immunology; 1995 Oct; 86(2):238-43. PubMed ID: 7490124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic use of monoclonal anti-IL-2 receptor antibody in cadaveric renal transplantation.
    Carpenter CB; Kirkman RL; Shapiro ME; Milford EL; Tiney NL; Waldmann TA; Zimmerman CE; Ramos EL; Strom TB
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):54-7. PubMed ID: 2683758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation.
    Langrehr JM; Glanemann M; Guckelberger O; Klupp J; Neumann U; Machens C; Lohmann R; Knoop M; Lobeck H; Schlag H; Keck H; Settmacher U; Bechstein WO; Neuhaus PJ
    Clin Transplant; 1998 Aug; 12(4):303-12. PubMed ID: 9686324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
    Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
    Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-dose daclizumab induction protocol in renal allograft recipients: a Chinese single center experience.
    Ji SM; Li LS; Cheng Z; Cheng DR; Sun QQ; Chen JS; Sha GZ; Liu ZH
    Transplant Proc; 2007 Jun; 39(5):1396-401. PubMed ID: 17580147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the improved effect of anti-TCR alpha beta monoclonal antibody on the induction of transplantation tolerance to the allogeneic skin graft in mice and its mechanisms].
    Hao J; Liu J; Xie S
    Zhonghua Yi Xue Za Zhi; 2001 May; 81(10):593-6. PubMed ID: 11798930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year follow-up of recipients of a kidney or heart transplant who received induction therapy with a monoclonal antibody against the interleukin-2 receptor.
    Wabbijn M; Balk AH; van Domburg RT; Vantrimpont PJ; van Riemsdijk IC; Baan CC; Weimar W; van Gelder T
    Exp Clin Transplant; 2004 Jun; 2(1):201-7. PubMed ID: 15859929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological follow-up of renal allograft recipients treated with the BMA 031 (anti-TCR) monoclonal antibody.
    Chatenoud L; Ferran C; Legendre C; Kurrle R; Kreis H; Bach JF
    Transplant Proc; 1990 Aug; 22(4):1787-8. PubMed ID: 2117809
    [No Abstract]   [Full Text] [Related]  

  • 14. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction, expression and characterization of humanized antibodies directed against the human alpha/beta T cell receptor.
    Shearman CW; Pollock D; White G; Hehir K; Moore GP; Kanzy EJ; Kurrle R
    J Immunol; 1991 Dec; 147(12):4366-73. PubMed ID: 1836485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study.
    Stratta RJ; Alloway RR; Lo A; Hodge E
    Transplantation; 2003 Apr; 75(8):1260-6. PubMed ID: 12717213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation.
    Kirkman RL; Shapiro ME; Carpenter CB; McKay DB; Milford EL; Ramos EL; Tilney NL; Waldmann TA; Zimmerman CE; Strom TB
    Transplantation; 1991 Jan; 51(1):107-13. PubMed ID: 1846250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular rejection episodes reduce success in renal graft outcome after therapy with BMA 031.
    Hillebrand G; Dendorfer U; Feucht HE; Brockmeyer C; Gokel JM; Illner WD; Abendroth D; Kasper C; Land W
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1092-3. PubMed ID: 1989156
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic use of monoclonal antibodies in kidney transplantation.
    Kreis H; Chkoff N; Vigeral P; Chatenoud L; Lacombe M; Campos H; Pruna A; Goldstein G; Bach JF; Crosnier J
    Adv Nephrol Necker Hosp; 1985; 14():389-407. PubMed ID: 3919540
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-αβ-T-cell receptor antibodies in the setting of laryngeal transplantation.
    Strome M; Lott DG
    Immunotherapy; 2010 Nov; 2(6):835-45. PubMed ID: 21091115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.